Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

World-First Achievement: SUSMED's Blockchain-Based Clinical Trial System Supports ...

5 November 2026 · By · Wire by Fusion42

Published

5 November 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

Japan

◆ Source

Read at streetinsider.com →

◆ Verified

Fusion42 · 5 November 2026 · Fusion42 review

SUSMED's blockchain-based clinical trial system 'SUSMED SDS' contributed to Japan's first pharmaceutical marketing authorization using industry-sponsored clinical trial data recorded on blockchain. The system reduces clinical trial monitoring workload and improves data integrity, supporting compliance with updated Good Clinical Practice regulations.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You face a newly open route to Japan's pharmaceutical market with blockchain-verified trial data now compliant under GCP laws. Start engaging regulators and clinical partners this quarter to build trust and slide ahead of competitors still using legacy systems.

◆ Coverage

1 source · 5 Nov 2026

◆ Related on Wire

◆ Topics

Healthblockchainclinical-trialsregtechpharma-approvalgcp-compliance